Illumina (NASDAQ:ILMN) reported Q2 EPS of $0.57, $0.07 worse than the analyst estimate of $0.64. Revenue for the quarter came in at $1.16 billion versus the consensus estimate of $1.22 billion.
GUIDANCE:
Illumina sees FY2022 EPS of $2.75-$2.90, versus the consensus of $4.12.